Dissecting The Potential Role Of Prevnar As An Anti-Myeloma Vaccine

被引：1
|
作者：
Noonan, Kimberly
Rudraraju, Lakshmi
Ferguson, Anna
Sidorski, Amy
Casildo, Andrea
Griffin, Ervin
Lee, Susan
Ghosh, Nilanjan
Matsui, William
Huff, Carol
Borrello, Ivan M.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1980.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1980
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
    Teramachi, Jumpei
    Miki, Hirokazu
    Nakamura, Shingen
    Hiasa, Masahiro
    Harada, Takeshi
    Abe, Masahiro
    JOURNAL OF BONE AND MINERAL METABOLISM, 2023, 41 (03) : 388 - 403
  • [32] The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma
    E Terpos
    M-A Dimopoulos
    O Sezer
    Leukemia, 2007, 21 : 1875 - 1884
  • [33] The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma
    Terpos, E.
    Dimopoulos, M-A
    Sezer, O.
    LEUKEMIA, 2007, 21 (09) : 1875 - 1884
  • [34] Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma
    Jandial, A.
    Hj, S.
    Mishra, K.
    Bhadada, S.
    Sood, A.
    Prakash, M.
    Meshram, A.
    Sandal, R.
    Lad, D.
    Aggarwal, R.
    Prakash, G.
    Vikas, S.
    Khadwal, A. R.
    Kumari, S.
    Varma, N.
    Varma, S. C.
    Malhotra, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 370 - 370
  • [35] Classic Anti-Myeloma Treatments Alter Circulating Immune Cell Subsets with Potential Implications for T Cell Immunotherapies in Multiple Myeloma
    Zhou, Xiang
    Wiethe, Sarah
    Wolff, Angelika
    Steinhardt, Max J.
    Afrin, Nazia
    John, Mara
    Riedhammer, Christine
    Xiao, Xianghui
    Munawar, Umair
    Mersi, Julia
    Han, Seungbin
    Waldschmidt, Johannes
    Riedel, Angela
    Topp, Max S.
    Duell, Johannes
    Einsele, Hermann
    Kortuem, K. Martin
    Rasche, Leo
    BLOOD, 2024, 144 : 4705 - 4706
  • [36] Synthetic phorboxazole a as a potent anti-leukemia and anti-myeloma agent.
    Uckun, FM
    Narla, RK
    Navara, C
    Forsyth, C
    BLOOD, 1999, 94 (10) : 197B - 197B
  • [37] The anti-myeloma effect of bortezomib is associated with osteoblastic activity.
    Zangari, M
    Najarian, KB
    Esseltine, DL
    Lee, CK
    Barlogie, B
    Elice, F
    Burns, MJ
    Yaccoby, S
    Richardson, P
    Sonneveld, P
    BLOOD, 2005, 106 (11) : 152A - 153A
  • [38] Cereblon Expression Is Required for the Anti-Myeloma Activity of Lenalidomide and Pomalidomide
    Zhu, Yuan Xiao
    Braggio, Esteban
    Shi, Chang-Xin
    Schmidt, Jessica
    Bruins, Laura
    Schuster, Steven R.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Bjorklund, Chad C.
    Orlowski, Robert Z.
    Stewart, A. Keith
    BLOOD, 2011, 118 (21) : 61 - 62
  • [39] Thiazolidinediones: A novel class of agents with anti-myeloma activity.
    Mitsiades, CS
    Mitsiades, N
    Poulaki, V
    Treon, SP
    Anderson, KC
    BLOOD, 2001, 98 (11) : 376A - 376A
  • [40] The ellipticine derivative NSC 338258 has anti-myeloma activity
    Tian, EM
    Stephens, O
    Holbeck, S
    Barlogie, B
    Shaughnessy, J
    BLOOD, 2005, 106 (11) : 944A - 944A
12345